The present invention provides the use of a compound of the Formula: (I) wherein R
1
is C
1-5
alkoxy, OCOC
1-3
Alkyl, O(CH
2
)
2
O(CH
2
)
2
O(CH
2
)
2
OMe, O(CH
2
)
2
O(CH
2
)
2
O(CH
2
)
2
OH or OH; R
2
is H, (CH
2
)
n
OH, OCH
3
, Hal or (II) or (III) R
3
is H or (CH
2
)
n
OH; and R
4
is C
1-6
alkyl, optionally substituted by one or more of Hal, OH, COCH
3
, NH
2
, NHCH
3
, NHMe, NMe
2
, OCOCH
3
, CO
2
H or esters or amides thereof where n is 1-5; and pharmaceutically acceptable salts thereof, in the manufacture of a medicament for use in modulating PKB activity.
本发明提供了一种使用以下化合物的方法:其中R1是C1-5烷氧基,OCOC1-3烷基,O(
CH2)2O( )2O( )2OMe,O( )2O( )2O( )2OH或OH;R2是H,( )nOH,OCH3,卤素或(II)或(III);R3是H或( )nOH;R4是C1-6烷基,可选择地被一个或多个卤素、OH、COCH3、NH2、NHCH3、NHMe、NMe2、OCOCH3、CO2H或其酯或酰胺所取代,其中n为1-5;以及其在制备用于调节PKB活性的药物中的药用盐。